Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 5.18 B5.25 B5.74 B5.85 B6.07 B 22.91 B Research & development ————— — Operating income 33.41 B34.02 B34.05 B30.33 B38.89 B 137.28 B Non-Operating Income, Total 6.22 B6.9 B7.53 B7.32 B7.32 B 29.07 B Interest expense, net of interest capitalized 23.58 B25.03 B25.47 B23.81 B23.82 B 98.14 B Non-Operating Income, excl. Interest Expenses -17.36 B-18.13 B-17.94 B-16.5 B-16.5 B -69.07 B Unusual income/expense ————— — Pretax income 18.41 B18.28 B18.74 B17.16 B20.48 B 74.67 B Equity in earnings ————— — Taxes 3.77 B3.3 B4.35 B4.13 B3.98 B 15.77 B Non-controlling/minority interest ————— — After tax other income/expense -600 M-379 M-169 M-161 M-513 M -1.22 B Net income before discontinued operations 14.64 B14.99 B14.39 B13.03 B16.49 B 58.9 B Discontinued operations ————— — Net income 14.64 B14.99 B14.39 B13.03 B16.49 B 58.9 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 14.32 B14.63 B14.04 B12.69 B16.15 B 57.51 B Basic earnings per share (Basic EPS) 5.085.255.084.645.95 20.92 Diluted earnings per share (Diluted EPS) 5.075.245.074.645.94 20.89 Average basic shares outstanding 2.82 B2.79 B2.76 B2.78 B2.72 B — Diluted shares outstanding 2.82 B2.79 B2.77 B2.78 B2.72 B — EBITDA 37.43 B37.45 B38.1 B37.69 B42.15 B 155.4 B EBIT 36.71 B36.87 B37.45 B34.98 B41.39 B 150.69 B Cost of revenue 3.31 B2.85 B3.4 B4.66 B2.51 B 13.41 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 505 M583 M654 M2.71 B761 M 4.71 B